TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
TCRX

Tscan Therapeutics Inc

Healthcare · Biotechnology

0.349$ -4.1% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TCRX
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
85.8% 73.3% 88.1% 62.3% 71.4% 78.9% 68.7%
84.6% 69.9% 85.8% 60.3% 49.0% 48.1% 66.6%
84.6% 69.9% 85.8% 60.3% 70.6% 78.2% 66.6%
13.0% 25.2% 6.3% 5.1% – – –
13.9% 185.4% 14.5% 50.1% 44.6% 35.1% 46.2%
4.9% 35.1% 11.3% 8.7% 11.0% 9.7% 8.2%
0.9% 2.8% 0.9% 1.8% 2.4% 1.2% 3.1%
2.0% 5.9% 0.9% 1.5% 0.9% 1.2% 0.5%
– – – 14.7% 9.8% 8.6% 14.2%
86.1% -85.4% 85.5% 49.9% 55.4% 64.9% 53.8%
-35.2% -87.5% -49.0% -79.6% -91.0% -101.1% -220.7%
50.5% 50.1% 12.7% 12.1% 24.1% 30.2% 56.8%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?